Rare Disease Strategy Deck

I need a seasoned biotech or pharma strategist who can quickly transform publicly available information into a concise, data-driven story for a client operating in the rare disease arena. Within 48 hours, I expect a polished slide deck—talking titles up front, logical narrative flow throughout—that dissects the competitive landscape and ends with pointed, defensible recommendations.

Scope of the analysis
Your work will zero-in on three pillars: current market leaders, emerging competitors, and the regulatory environment shaping this therapeutic area. Secondary research should draw only on reputable industry reports, scientific publications, and market-analysis databases (e.g., EvaluatePharma, Clarivate, PubMed, GlobalData). I am not after a catalog of facts; I want a clear viewpoint supported by numbers.

Strategic focus
The recommendations must speak directly to market entry strategies and risk management while weaving in competitive intelligence that highlights potential disruptors and quantifies their impact. Please be ready to justify your stance during a brief follow-up call.

Deliverables (due in 2 days)
• 15–20 slide PowerPoint deck, client-ready, with talking titles, charts, and cited sources
• An Excel file or similar worksheet showing key data tables and calculations
• A short explanatory note (one page) summarizing key assumptions

Acceptance criteria
The deck reads as a single narrative, each source is fully cited, and every recommendation is tied to a specific data point or trend.

If you have completed comparable projects—especially in rare diseases—attach a sample slide or anonymized case study so I can gauge fit. Budget is flexible and will reflect the depth of your experience and the quality of previous work. DM me to align on scope and next steps.